On 1 avoid lists
|In 92 skincare routines
A derivative of the most potent form of vitamin A, retinoic acid. The ingredient can be sold under name Granactive Retinoid. Note that if a skincare brand discloses the concentration of Granactive Retinoid in a product, the concentration refers to a diluted form of Hydroxypinacolone Retinoate: 1% of Granactive Retinoid corresponds to 0.1% of Hydroxypinacolone Retinoate. Hydroxypinacolone Retinoate (HPR) is a unique derivative of retinoic acid because it can directly work in the skin and does not require additional conversion steps. According to studies done by the manufacturer on models of human skin (not real people), this derivative is more effective than other cosmetic versions of retinoids (such as retinol, retinaldehyde, and retinyl palmitate), and, at the same time, causes less irritation. It has been also demonstrated to be more stable than retinol which makes formulating with easier and increases the chances that a product with it will maintain its effectiveness after opening. The packaging should still ideally be air-tight. HPR is available over the counter in the EU, UK, Asia, Australia and New Zealand, but is only with a prescription in Canada.
innisfreeSerum-Infused Sheet Mask - Green Tea PDRN™ Firming
VT CosmeticsBuy VT Cosmetics Reedle Shot Reti-A 100 Trial Pack in Australia - Korean Skincare Online
Shani Darden Skin CareBody Reform Treatment Serum
MANSCAPEDFace Retinoid Serum
CliniqueAll About Eyes Brightening Serum Concentrate
Typology ParisSérum Yeux Rides et Ridules — Rétinoïdes 0,1% + Acide hyaluronique
.50 fl ozHPR Eye Cream
skintificRose PDRN Niacinamide Glow Boost Clay Stick
IOPEExpert Retinol RX™ 2% Reti-Jection Serum for Wrinkles
AizenPhytorevita AmpouleThe number of open comedones, closed comedones and papules showed statistically significant decrease over time. Closed comedones responded faster than open comedones with significant difference seen as early as day 45. Both open and closed comedones continued to decrease in lesion count throughout the entire study period. The number of papules decreased throughout the treatment period with significant difference between baseline and days 90 and 120. Median sebumeter values showed significant decrease over time. Mild itching was experienced by 3-13% of patients from days 15 to 120, with highest percentage at day 45. Mild burning occurred in 7% of patients at day 45 but was absent at days 90 and 120. No edema was reported by any of the patients throughout the study period.
Safety and Efficacy of Retinsphere® Technology and Biopep-15 in the treatment of Acne in Asian Population
a significative improvement of all the observed characteristics has been recorded. Also the global skin photoaging evaluation, performed at the times T0 and T12 with the Glogau scale, showed a significative improvement (P<0.001).
Clinical evaluation of the efficacy of a new retinoic-complex (Retinsphere®) product for the treatment of skin photoaging
A 41% mean reduction in the GAGS score was observed; a 40.8% mean reduction of total lesions was recorded; 15.3% of patients experienced mild to moderate local side effects (dryness, peeling, erythema, burning). No patients stopped the treatment because of these side effects.
Treatment of mild to moderate acne with a fixed combination of hydroxypinacolone retinoate, retinol glycospheres and papain glycospheres
Most of patients had satisfactory therapeutic response with a reduction of GAGS global score of 70%. Digital images confirmed clinical improvement (Figure 1). Micro-comedones and macro-comedones showed respectively a reduction of 38% and of 65%. Follicular biopsy proved a reduction about 60% in the density of micro and macro- comedones. No patients dropped out the study because of side effects and tolerability was very good in 90% of our sample.
Evaluation of efficacy and safety of the combinated use of two topic retinoids to treat mild / moderate acne.
In percentage terms, the reduction of the MASI at the end of the study on the side treated with the product was 74% (31%) vs. a reduction of 55% (36%) on the side that received the vehicle with SPF, with this being a significant difference (P = 0.009).
Assessment of the efficacy and tolerance of a new combination of retinoids and depigmenting agents in the treatment of melasma